Medical Oncology Grand Rounds

2018-2019 Academic Year

Date Speaker Title
Sep 7, 2018 Melissa A. Reimers, MD
University of Michigan, Ann Arbor, MI
Precision Medicine and Immunotherapy in Metastatic Prostate Cancer
Sep 14, 2018 Jonathan R. Strosberg, MD
Moffitt Cancer Center, Tampa, FL
Overview of Treatments for Metastatic Gastroenteropancreatic Neuroendocrine Tumors
Sep 28, 2018 Matthew J. Ellis, MD, PhD
Baylor College of Medicine, Houston, TX
Breast Cancer Proteogenomics
Oct 5, 2018 Benjamin Tan Localized Rectal Cancer: Navigating Shifting Paradigms
Oct 12, 2018 Aabha Oza Management of Advanced Renal Cell Carcinoma
Oct 19, 2018 Armin Ghobadi CAR-T Cell Therapy and Its Complications
Oct 26, 2018 Nabil M. Ahmed, MD, MPH
Baylor College of Medicine, Houston, TX
A Homing System Targets Therapeutic T Cells to Brain Cancer
Nov 2, 2018 Kenneth C. Anderson, MD
Dana-Farber Cancer Institute, Boston, MA
Novel Therapeutic Strategies in Multiple Myeloma
Nov 9, 2018 Nkiruka Ezenwajiaku Molecular Classification of Triple Negative Breast Cancer
Ramon Jin GI Organoids in Cancer Research
Dec 7, 2018 Amber Xu Target Therapy in Non-Small Cell Lung Cancer
Dec 14, 2018 Milan Chheda Using Zika Virus to Target Glioblastoma Stem Cells
Jan 4, 2019 Kristen Sanfilippo Cancer Associated Thrombosis: Prevention to Treatment
Jan 11, 2019 Brett Herzog Fibrosis Modulates Lung Cancer Immunity and Progression
Ramzi Abboud Invariant NKT Cells: Harnessing Their Immunoregulatory and Effector Functions
Jan 18, 2019 David DeNardo Targeting the Pancreas Cancer Tumor Microenvironment to Improve Response to Immunotherapy
Jan 25, 2019 Gradon Nielsen Economic Challenges in Modern Oncology and the Need for Innovation
Lauren Shea Treatment of Brain Metastases in Non-Small Cell Lung Cancer
Feb 1, 2019 Kian Lim Targeting the Innate Immune Inflammatory Pathway in Pancreatic Cancer
Feb 8, 2019 Bruna Pellini Ferreira Urinary cfDNA in Lung Cancer Surveillance: Present and Future Directions
Daniel Guy Bispecific Antibodies for Treatment of AML
Feb 15, 2019 Meagan Jacoby Can Measurable Residual Disease Monitoring Post-Transplant Improve Outcomes for MDS Patients?
Feb 22, 2019 James Hsieh Clinical and Translational Kidney Cancer Research: Now & Future
Mar 1, 2019 Katherine Clifton, MD
MD Anderson Cancer Center, Houston, TX
Exploring Oral Therapy Options in Geriatric Oncology: Analysis of Toxicity and Efficacy Of CDK4/6 Inhibitors in Metastatic Breast Cancer
Mar 15, 2019 Sunyoung Lee, MD, PhD
Roswell Park Comprehensive Cancer Center, Buffalo, NY
Immune Profiling and Prognostication of Lung and Pancreatic Adenocarcinoma
Mar 22, 2019 Karin Hickey, MD
Division of Endocrinology, Metabolism & Lipid Research
Endocrine Disorders in Cancer Patients
Mar 29, 2019 Angela Hirbe Clinical Challenges in the Diagnosis and Management of Neurofibromatosis-associated MPNSTs
Apr 5, 2019 John Welch Integrating Next-Generation Sequencing Into AML and MDS Clinical Trials
Apr 19, 2019 Matthew Christopher AML and the Graft-Versus-Leukemia Effect
Apr 26, 2019 Vanessa Eulo Immunotherapy in Advanced Sarcoma
Scott Goldsmith Unfolding the Unfolded Protein Response: Implications for Cancer Therapy
May 3, 2019 Charles Kaufman Epigenetic Regulators of Melanoma Initiation
May 10, 2019 David Spencer Understanding Aberrent DNA Methylation in Leukemia
May 17, 2019 Tanner Johanns Neoantigens as Therapeutic Targets in Glioblastoma
May 24, 2019 Ryan Day Targeting Apoptosis in AML
Mary-Kate Malecek Novel Therapies in Primary CNS Lymphoma
Jun 7, 2019 Amber Afzal CDK9 Inhibition in Acute Myeloid Leukemia
Miriam Jacobs Use of Cytokine Induced Memory Like NK Cells for Relapsed Refractory AML
Jun 14, 2019 Michael Green, MD
MD Anderson Cancer Center, Houston, TX
Epigenetic Targeting of B-Cell Lymphoma
Jun 21, 2019 Obi Griffith Surveying the Genomic Landscape of Tumors and Tumor Models - The Next Frontier
Jun 28, 2019 Gerald P. Linette, MD, PhD
University of Pennsylvania, Philadelphia, PA
Immunological Ignorance of Solid Tumors